FDA — authorised 3 July 1996
- Application: NDA020616
- Marketing authorisation holder: ALLERGAN
- Local brand name: KADIAN
- Indication: CAPSULE, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 KADIAN in United States
FDA authorised KADIAN on 3 July 1996
Marketing authorisations
FDA
- Status: approved
KADIAN in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is KADIAN approved in United States?
Yes. FDA authorised it on 3 July 1996; FDA has authorised it.
Who is the marketing authorisation holder for KADIAN in United States?
ALLERGAN holds the US marketing authorisation.